Population Health Research Institute
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Population Health Research Institute sits in the top decile of US sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count).
Population Health Research Institute: 21 sponsored US clinical trials, 7 recruiting.
Population Health Research Institute sponsors 21 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 10 completed. 11 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Atrial Fibrillation, with 3 trials.
Top-decile sponsor footprint
Population Health Research Institute ranks in the top decile of sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
10 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
21 total, page 1 of 1
International CRDS Registry
NCT06508164
Pericardiotomy in Cardiac Surgery
NCT06486636
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
NCT05701358
Evaluation of A Clinical Diagnostic Test for CRDS
NCT06188689
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
NCT04774159
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393
Benzodiazepine-free Cardiac Anesthesia for Reduction of Postoperative Delirium
NCT03928236
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
NCT03950076
PeriOperative ISchemic Evaluation-3 Trial
NCT03505723
Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)
NCT03310125
Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry
NCT03048825
Preventing pAIn With NMDA Antagonists - Steroids in Thoracoscopic lObectomy Procedures (PAIN-STOP) Pilot Trial
NCT02950233
Young ESUS Patient Registry
NCT03185520
Tetralogy of Fallot for Life
NCT02968264
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
NCT01938248
Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery
NCT01842568
Management of Myocardial Injury After Noncardiac Surgery Trial
NCT01661101
A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI
NCT01149044
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
NCT01097330
First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)
NCT00392054
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 8 |
| Phase 4 | 3 |
Where Population Health Research Institute enrollment is open (later-stage tilt)
7 recruiting of 21 indexed (33% open); 10 completed (48%).
Phase mix: 11 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Atrial Fibrillation (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Population Health Research Institute: open-pipeline peers nationwide
Peers matched on 21 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Population Health Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 21 trials (± recruiting share)
- AEterna Zentaris · 21 trials · 0% recruiting
- Amphastar Pharmaceuticals · 21 trials · 5% recruiting
- Apellis Pharmaceuticals · 21 trials · 10% recruiting
- Array Biopharma, now a wholly owned subsidiary of Pfizer · 21 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Population Health Research Institute page
21 registered trials is a research-attention snapshot, not an endorsement of Population Health Research Institute or any single study.
- 7 of Population Health Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Atrial Fibrillation is the condition Population Health Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atrial Fibrillation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Population Health Research Institute pipeline card: 21 registered trials from official public datasets.Report a data error.